Acer Therapeutics Inc.·4

Dec 1, 4:02 PM ET

Schelling Chris 4

4 · Acer Therapeutics Inc. · Filed Dec 1, 2022

Insider Transaction Report

Form 4
Period: 2022-11-29
Schelling Chris
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2022-11-29$1.22/sh+819,672$1,000,0002,712,529 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION